EKF signs up Peruvian distributor; wins €1 m contract

Wednesday, Sep 29 2010 by
1
EKF signs up Peruvian distributor wins 1 m contract

EKF Diagnostics (LON:EKF) , the Point of Care in-vitro diagnostics company, announced that it has signed a distribution agreement with Diagnostica Peruana SAC in Peru. Under the agreement, Diagnostica Peruana will distrubute and provide customer support for EKF's Hemo-Control product. Hemo-Control is a Point of Care blood haemoglobin and hematocrit test instrument designed for use in doctors' offices. The Hemo-Control system is used to screen for illnesses such as diabetes and anaemia.

EKF also received a Hemo-Control order worth over €1 million from the Peruvian Ministry of Health (MINSA). The contract is for the purchase of 3,000 Hemo-Control devices along with an initial two month supply of consumable cuvettes (transparent tubes which hold blood test samples). The Company is currently tendering for the ongoing supply of cuvettes to MINSA, and because the Hemo-Control device requires EKF's proprietary cuvettes the company is confident that this effort will be successful. Recurring sales of consumables such as the cuvettes used in Hemo-Control tests are a key component of EKF's business model.

In other news, EKF’s board announced that CEO Julian Baines and Exec Chairman David Evans have been granted options on EKF Diagnostics Shares which amount to 6% each of the companies issued share capital.


About the Author's Company

LCF Research Profile Image Promotional
LCF Research

LCF Research is an independent, investor led investment research resource for private investors and fund managers.  We do not seek to replicate the full coverage model of stockbrokers and independent research houses.  Instead we aim to ask the key due diligence questions that should be posed prior to an investment… ...read more or visit website »


Disclaimer:  

This note was prepared by LCF Research Limited using information provided by the subject company’s management or publically available news sources. No representations are made nor warranties given (express or implied) in relation to accuracy and completeness. This document is not an invitation to invest in the subject company and does not purport to contain all the necessary information that a prospective investor might require. LCF Research Limited recommends prospective investors to conduct their own thorough independent analysis of the subject company and the information contained in this note or referred to above.


Do you like this Post?
Yes
No
1 thumb up
0 thumbs down
Share this post with friends



EKF Diagnostics Holdings Plc designs, develops, manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company is focused within the In-Vitro Diagnostic devices (IVD) market place. Other services include the servicing and distribution of other company products under separate distribution agreements. The Company operates in the United States, Germany, Poland, Russia, United Kingdom and Ireland. The Company is also a manufacture and distribution of organ injury biomarkers specializing in acute injury to kidneys (AKI), liver and pancreas. In March 2014, EKF Diagnostics Holdings PLC acquired Separation Technology Inc. more »

Share Price (AIM)
30p
Change
-1.3  -4.0%
P/E (fwd)
21.7
Yield (fwd)
n/a
Mkt Cap (£m)
126.6



  Is EKF Diagnostics Holdings fundamentally strong or weak? Find out More »


What's your view on this article? to Comment Now

 
 
You are feeling neutral

Use the £ sign in front of a ticker to turn £VOD into Vodafone PLC

You can track all @StockoChat comments via Twitter


About LCF Research

LCF Research is an independent, investor led investment research resource for private investors and fund managers.



Stock Picking Tutorial Centre



Stock Picking Simplified

Stockopedia takes your stock picking to the next level with cutting edge Stock Reports & Screening tools.


Get started
or Take a Tour to find out more.